Last updated: March 5, 2024
Sponsor: IHF GmbH - Institut für Herzinfarktforschung
Overall Status: Active - Recruiting
Phase
N/A
Condition
Myocardial Ischemia
Occlusions
Chest Pain
Treatment
No intervention planned
Clinical Study ID
NCT05324683
ILUMIEN-V - AERO V 1.2
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years
- Patients with evidence of myocardial ischemia (e.g. stable angi-na, silent ischemia,unstable angina, or acute myocardial infarc-tion) undergoing OCT-guided lesionevaluation (OCT-scan using the devices must be performed either to guide PCI (following the MLD-MAX-algorithm) or to investigate a coronary lesion for fur-therclinical treatment)
- Written informed consent (defined as legally effective, docu-mented confirmation of asubject's (or their legally authorized representative or guardian) voluntary agreementto participate in a particular clinical study) to participate in this clinicalinves-tigation
Exclusion
Exclusion Criteria:
- none
Study Design
Total Participants: 2000
Treatment Group(s): 1
Primary Treatment: No intervention planned
Phase:
Study Start date:
May 04, 2023
Estimated Completion Date:
May 30, 2025
Study Description
Connect with a study center
Universitätsklinikum Frankfurt - Med. Klinik 3 - Kardiologie
Frankfurt am main, 60590
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.